Home
>
National Drug Code (NDC)
>
PARNATE
PARNATE - 0007-4471-20 - (tranylcypromine sulfate)
Drug Information of PARNATE
| Product NDC: | 0007-4471 |
| Proprietary Name: | PARNATE |
| Non Proprietary Name: | tranylcypromine sulfate |
| Active Ingredient(s): | 10 mg/1 & nbsp; tranylcypromine sulfate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of PARNATE
| Product NDC: | 0007-4471 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA012342 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19890623 |
Package Information of PARNATE
| Package NDC: | 0007-4471-20 |
| Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE (0007-4471-20) |
NDC Information of PARNATE
| NDC Code | 0007-4471-20 |
| Proprietary Name | PARNATE |
| Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (0007-4471-20) |
| Product NDC | 0007-4471 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | tranylcypromine sulfate |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 19890623 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | TRANYLCYPROMINE SULFATE |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA] |
